文献速递泌尿男性生殖肿瘤

术前MRI作为根治性前列腺切除术后预后因素的系统综述与荟萃分析

Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Oncol · 2026-01-01

结果显示,MRI检测的包膜外侵犯、精囊侵犯及定量MRI特征(PI-RADS 4/5分、肿瘤直径≥20 mm、ADC<0.9×10-3 mm2/s)均独立关联生化复发、转移失败及前列腺癌特异性死亡。

要点

  • 术前MRI检测的包膜外侵犯(mrT3a)独立关联生化复发(HR 2.16)、转移失败(HR 3.18)和前列腺癌特异性死亡(HR 10.93)。
  • 精囊侵犯(mrT3b)独立关联生化复发(HR 2.74)和转移失败(HR 5.58)。
  • PI-RADS 4/5分、肿瘤直径≥20 mm、ADC<0.9×10-3 mm2/s均与生化复发相关。

核心结论

  • 术前MRI对接受根治性前列腺切除术男性的生化复发、转移失败和前列腺癌特异性死亡具有独立预后价值,即使校正已建立的临床病理因素后仍显著。

研究设计与样本

  • 纳入标准为评估术前前列腺MRI并报告多变量时间-事件分析(生化复发、转移失败、前列腺癌特异性死亡)的研究。
  • 采用随机效应模型合并风险比(HR),使用Quality in Prognostic Studies工具评估研究质量。

主要发现

  • MRI检测的包膜外侵犯(mrT3a)与生化复发独立相关(合并HR 2.16,95%CI 1.84-2.54),与转移失败相关(HR 3.18,95%CI 2.04-4.97),与前列腺癌特异性死亡相关(HR 10.93,95%CI 5.05-23.65)。
  • MRI检测的精囊侵犯(mrT3b)与生化复发独立相关(HR 2.74,95%CI 2.06-3.65),与转移失败相关(HR 5.58,95%CI 1.15-27.13)。
  • PI-RADS评分4或5与生化复发相关(HR 2.15,95%CI 1.82-2.55)。
  • 肿瘤直径≥20 mm与生化复发相关(HR 2.35,95%CI 1.71-3.24)。
  • 表观扩散系数(ADC)值<0.9×10-3 mm2/s与生化复发相关(HR 2.39,95%CI 1.82-3.14)。

关键数值与推荐

  • mrT3a和mrT3b疾病的异质性为中等(I2<65%),未检测到显著发表偏倚。

临床怎么用

  • 术前MRI参数可用于根治性前列腺切除术患者的风险分层,辅助识别高危患者以指导治疗决策和随访策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Accurate pretreatment prostate cancer risk assessment is essential to balance long-term treatment benefits and harm. Although some clinical and pathological parameters are established prognostic factors, the role of imaging parameters in prognostication is unclear. OBJECTIVE: To assess the prognostic value of pretreatment magnetic resonance imaging (MRI) parameters for oncological outcomes in men undergoing radical prostatectomy. DATA SOURCES AND STUDY SELECTION: A systematic literature search of MEDLINE, Embase, and Scopus was performed from inception through March 2025. Studies were included if they evaluated pretreatment prostate MRI in men undergoing radical prostatectomy and reported multivariable, time-to-event analyses for the outcomes of biochemical recurrence, metastatic failure, and prostate cancer-specific mortality. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data and assessed study quality using the Quality in Prognostic Studies tool. Random-effects meta-analysis was performed to pool hazard ratios (HRs). MAIN OUTCOMES AND MEASURES: The primary outcome was biochemical recurrence. Secondary outcomes included metastatic failure and prostate cancer-specific mortality. RESULTS: Forty studies were included (comprising 24 941 patients). Extraprostatic extension (mrT3a disease) detected with MRI was independently associated with biochemical recurrence (pooled HR, 2.16 [95% CI, 1.84-2.54]), metastatic failure (HR, 3.18 [95% CI, 2.04-4.97]), and prostate cancer-specific mortality (HR, 10.93 [95% CI, 5.05-23.65]). Seminal vesicle invasion (mrT3b disease) detected with MRI was also independently associated with biochemical recurrence (HR, 2.74 [95% CI, 2.06-3.65]) and metastatic failure (HR, 5.58 [95% CI, 1.15-27.13]). The following quantitative MRI features were prognostic for biochemical recurrence: Prostate Imaging Reporting and Data System score of 4 or 5 (HR, 2.15 [95% CI, 1.82-2.55]), large tumor size (tumor diameter ≥20 mm; HR, 2.35 [95% CI, 1.71-3.24]), and apparent diffusion coefficient values less than 0.9 × 10-3 mm2/s (HR, 2.39 [95% CI, 1.82-3.14]). Heterogeneity was moderate (I2 < 65% for mrT3a and mrT3b disease) and no significant publication bias was detected. CONCLUSIONS AND RELEVANCE: This systematic review and meta-analysis found that pretreatment MRI provides independent prognostic value for biochemical recurrence, metastatic failure, and prostate cancer-specific mortality in men undergoing radical prostatectomy, even when adjusted for established clinicopathologic factors.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Agrotis G, Ursprung S, van der Steen C, et al. Pretreatment MRI as a Prognostic Factor After Radical Prostatectomy: A Systematic Review and Meta-Analysis. JAMA Oncol. 2026. PMID: 41926088. doi:10.1001/jamaoncol.2026.0371

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。